NASDAQ

Immunovant, Inc. (IMVT)

♥ 391 Thanks from members

Live price chart, market sentiment, and community perspectives for Immunovant, Inc. (NASDAQ: IMVT).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Roivant SciencesLeadership: Pete Salzmann (CEO)Leadership: Erik Harris (Chief Commercial Officer)Holder: Roivant SciencesHolder: Fidelity Management and ResearchHolder: Baker Bros. AdvisorsBatoclimabIMVT-1402#IMVT#Immunovant#autoimmune diseases#biopharma#NASDAQ stock